Schonfeld Strategic Advisors’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,351
| Closed | -$213K | – | 1901 |
|
|
2024
Q3 | $213K | Sell |
6,351
-165,242
| -96% | -$5.54M | ﹤0.01% | 1648 |
|
|
2024
Q2 | $4.3M | Buy |
+171,593
| New | +$4.3M | 0.03% | 518 |
|
|
2022
Q4 | – | Sell |
-25,465
| Closed | -$650K | – | 2486 |
|
|
2022
Q3 | $650K | Buy |
+25,465
| New | +$650K | 0.01% | 1540 |
|
|
2019
Q2 | – | Sell |
-91,600
| Closed | -$6.69M | – | 974 |
|
|
2019
Q1 | $6.69M | Buy |
91,600
+31,900
| +53% | +$2.33M | 0.23% | 118 |
|
|
2018
Q4 | $3.81M | Buy |
59,700
+20,000
| +50% | +$1.28M | 0.15% | 196 |
|
|
2018
Q3 | $3.96M | Buy |
39,700
+34,000
| +596% | +$3.39M | 0.18% | 166 |
|
|
2018
Q2 | $405K | Sell |
5,700
-1,275
| -18% | -$90.6K | 0.02% | 575 |
|
|
2018
Q1 | $726K | Buy |
+6,975
| New | +$726K | 0.05% | 395 |
|